Ocugen OCGN is advancing a late-stage ophthalmology pipeline built around one-time gene therapies for retinal diseases with ...

Gardeners love a good secret, especially one that turns waste into something wildly useful. Hidden in plain sight sits one of ...

Compass Pathways is already in the final stage of development on a psychedelic medicine to treat depression.

This isn't a bourbon, it's not a rye; it's a sour mash whiskey.

Planet Labs is transitioning from a data provider to a real-time geospatial intelligence platform, leveraging AI-powered, ...

HIVE Digital Technologies (HIVE) stock gains after closing $115M exchangeable notes deal to fund AI infrastructure and data ...

Century Therapeutics (IPSC) analysis: autoimmune CAR-cell pivot, CNTY-813 Type 1 diabetes upside, cash burn cuts, rNPV fair ...

This AI Insights Quick Read series examines a growing risk for innovation-driven businesses: how routine generative AI use can weaken ...

In the past year or so, people have been increasingly outspoken about suspicions that their injectors are “watering down” ...

New research reveals that even the most advanced hospital ventilation systems can leave viral particles lingering in the air, ...

Bitcoin US is trading up at 79,135.65 +3,288.97 (+4.34%) on easing geopolitical tensions and institutional buying. HIVE ...

SALT LAKE CITY, UT / ACCESS Newswire / April 23, 2026 / In the first calendar quarter (1Q) of 2026, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results which were consistent with its ...